Although healthcare disparities, particularly in surgery and cancer, have been abundantly described, potential solutions have been lacking. Aptly presented by Lee and colleagues in this issue of the Annals of Surgical Oncology, disparities can occur anywhere along the patient care continuum.1 Because of the numerous sources of healthcare disparities, a concerted effort is needed to successfully mitigate them.
2,3Lee and colleagues highlight three interconnected sources of healthcare disparities within the context of cancer: obtaining healthcare access, provider-level factors, and patient-level factors. Using the National Cancer Data Base, the authors investigated whether the differences in receipt of neoadjuvant therapy and survival for adolescents and young adults (AYAs; aged 15-39 years) with clinical stage II-III rectal cancer were associated with race and ethnicity (non-Hispanic white, Hispanic, black, and others). They discovered that nonoperative management occurred most frequently in blacks (22.4 %) and Hispanics (21.6 %) compared with non-Hispanic whites (12.3 %; p \ 0.0001). On multivariable analysis, insurance coverage rather than race/ethnicity was associated with undergoing surgery. Similarly, neoadjuvant therapy was omitted more frequently in blacks (37.9 %) and Hispanics (42.2 %) compared with non-Hispanic whites (27.9 %; p \ 0.05).On multivariable analysis, both insurance coverage and race/ethnicity were associated with receipt of neoadjuvant therapy. On multivariable survival analysis, lack of insurance [hazard ratio (HR) 1.71, 95 % confidence interval (CI) 1.08-2.70] and having government insurance (HR 1.86, 95 % CI 1.33-2.59) not race/ethnicity were most significantly associated with poorer survival. Taken together, the data argue that socioeconomic status, rather than sociodemographic status, account for the survival differences in this AYA population.